• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    enVVeno Medical Corporation - Common Stock (NQ:NVNO)

    6.910 -0.420 (-5.73%)
    Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 30,083
    Open 7.300
    Bid (Size) 4.590 (100)
    Ask (Size) 9.500 (200)
    Prev. Close 7.330
    Today's Range 6.601 - 7.570
    52wk Range 6.601 - 27.27
    Shares Outstanding 20,216,176
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
    CEO-led series gives investors the story - straight talk, no B.S., no corporate spin Real answers to what investors need to know about enVVeno and why they need to know it Watch the next episode here 
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
    Leading venous interventionalist Karen B. Garby, MD, DABVLM, RPhS, to present the enVVe ® System, a minimally invasive replacement venous valve currently being evaluated in a U.S. pivotal study An... 
    From enVVeno Medical Corporation
    Via ACCESS Newswire

    Performance

    52-Week Range 74.7% below 52-week high
    6.910
    6.6052W Low 27.2752W High
    1 Week 18.2% below 1-week high
    6.601W Low 8.451W High

    enVVeno Medical Corporation - Common Stock (NVNO) traded between $6.60 and $27.27 over the past 52 weeks and last traded at $6.91, 74.7% below its 52-week high. Over the past week it ranged between $6.60 and $8.45.

    Past 12 Months
    -7.5%
    -24.1%
    -31.7%
    -46.6%
    -43.6%
    -72.2%
    1W -$0.56
    1M -$2.19
    3M -$3.20
    6M -$6.04
    YTD -$5.34
    1Y -$17.94

    NVNO was -72.2% over the past year, -46.6% over six months, -43.6% year to date, -7.5% in the last week.

    12 Months vs Market
    NVNO
    -72.2%
    DIA
    +13.3%
    SPY
    +14.4%
    QQQ
    +16.3%
    IWM
    +13.7%

    Over the past 12 months NVNO returned -72.2% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

    Volume & Liquidity 1.16× 3-mo avg
    Today 30,083 3-mo avg 26.0K
    1W
    56.3K
    1M
    35.4K
    3M
    26.0K
    6M
    21.0K
    YTD
    20.3K
    1Y
    19.6K

    NVNO most recently traded 30,083 shares against a 3-month average daily volume of 26.0K.

    More News

    Read More
    News headline image
    enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
    From enVVeno Medical Corporation
    Via ACCESS Newswire
    News headline image
    enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
    Via ACCESS Newswire
    News headline image
    enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
    Via ACCESS Newswire
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    enVVeno Medical Announces Reverse Stock Split
    Via ACCESS Newswire
    News headline image
    enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
    Via Benzinga
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Which stocks are moving on Friday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is enVVeno Medical Corporation - Common Stock publicly traded?
    Yes, enVVeno Medical Corporation - Common Stock is publicly traded.
    What exchange does enVVeno Medical Corporation - Common Stock trade on?
    enVVeno Medical Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for enVVeno Medical Corporation - Common Stock?
    The ticker symbol for enVVeno Medical Corporation - Common Stock is NVNO on the Nasdaq Stock Market
    What is the current price of enVVeno Medical Corporation - Common Stock?
    The current price of enVVeno Medical Corporation - Common Stock is 6.910
    When was enVVeno Medical Corporation - Common Stock last traded?
    The last trade of enVVeno Medical Corporation - Common Stock was at 10/22/26 04:00 PM ET
    What is the market capitalization of enVVeno Medical Corporation - Common Stock?
    The market capitalization of enVVeno Medical Corporation - Common Stock is 139.69M
    How many shares of enVVeno Medical Corporation - Common Stock are outstanding?
    enVVeno Medical Corporation - Common Stock has 140M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.